These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25459192)

  • 1. Rectal pre-treatment with ozonized oxygen (O3) aggravates clinic status in septic rats treated with amoxicillin/clavulanate.
    Martín-Barrasa JL; Méndez Cordovez C; Espinosa de los Monteros y Zayas A; Juste de Santa Ana MC; Clavo Varas B; Herráez Thomas P; Bordes Benitez A; Montoya-Alonso JA; García-Bello M; Artiles Campelo F; Tejedor-Junco MT
    Enferm Infecc Microbiol Clin; 2015; 33(7):469-75. PubMed ID: 25459192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment with ozonized oxygen (O3) aggravates inflammation in septic rats.
    Torossian A; Ruehlmann S; Eberhart L; Middeke M; Wulf H; Bauhofer A
    Inflamm Res; 2004 Aug; 53 Suppl 2():S122-5. PubMed ID: 15338062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of tazobactam/piperacillin in lethal peritonitis is enhanced after preconditioning of rats with O3/O2-pneumoperitoneum.
    Bette M; Nüsing RM; Mutters R; Zamora ZB; Menendez S; Schulz S
    Shock; 2006 Jan; 25(1):23-9. PubMed ID: 16369182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amoxicillin/clavulanate (Augmentin) resistant Escherichia coli in bacterial peritonitis after abdominal surgery--clinical outcome in ICU patients.
    Rahnama'i MS; Wagenvoort JH; van der Linden CJ
    Neth J Med; 2009 May; 67(5):173-6. PubMed ID: 19581666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microbiology of bacterial peritonitis due to appendicitis in children.
    Obinwa O; Casidy M; Flynn J
    Ir J Med Sci; 2014 Dec; 183(4):585-91. PubMed ID: 24346630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
    Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J
    Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of amoxicillin-clavulanate and resistance in Escherichia coli over a 4-year period.
    Natsch S; Conrad C; Hartmeier C; Schmid B
    Infect Control Hosp Epidemiol; 1998 Sep; 19(9):653-6. PubMed ID: 9778163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of secondary peritonitis: is a less expensive broad-spectrum antibiotic as effective as a carbapenem?
    Genné D; Menetrey A; Jaquet A; Indino P; Sénéchaud C; Siegrist HH
    Dig Surg; 2003; 20(5):415-20. PubMed ID: 12900532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.
    Rodríguez-Baño J; Navarro MD; Retamar P; Picón E; Pascual Á;
    Clin Infect Dis; 2012 Jan; 54(2):167-74. PubMed ID: 22057701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
    Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
    Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality risks associated with empirical antibiotic activity in Escherichia coli bacteraemia: an analysis of electronic health records.
    Yoon CH; Bartlett S; Stoesser N; Pouwels KB; Jones N; Crook DW; Peto TEA; Walker AS; Eyre DW
    J Antimicrob Chemother; 2022 Aug; 77(9):2536-2545. PubMed ID: 35723965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.
    Hooton TM; Scholes D; Gupta K; Stapleton AE; Roberts PL; Stamm WE
    JAMA; 2005 Feb; 293(8):949-55. PubMed ID: 15728165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive pneumoperitoneum with ozonized oxygen as a preventive in lethal polymicrobial sepsis in rats.
    Schulz S; Rodriguez ZZ; Mutters R; Menendez S; Bette M
    Eur Surg Res; 2003; 35(1):26-34. PubMed ID: 12566784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pentoxifylline on inflammation and lung dysfunction in ventilated septic animals.
    Oliveira-Júnior IS; Oliveira WR; Cavassani SS; Brunialti MK; Salomao R
    J Trauma; 2010 Apr; 68(4):822-6. PubMed ID: 20065880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis.
    Huelves L; Gracia M; Del Prado G; Rodríguez-Cerrato V; Martínez-Marín C; Ponte C; Soriano F; Coronel P; Gimeno M; Blanco J
    Int J Antimicrob Agents; 2006 Aug; 28(2):151-3. PubMed ID: 16815688
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of cefaclor vs amoxicillin/clavulanate in pediatric pharyngotonsillitis.
    Haczyński J; Chmielik M; Bien S; Kawalski H; Zawadzka-Głos L; Mierzwa T; Zyłka S; Moś M; Szendo-Kita J; Mozejko-Pastewka B; Czarnocki KJ; Rek M
    Med Sci Monit; 2003 Mar; 9(3):PI29-35. PubMed ID: 12640354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors for amoxicillin-clavulanate-resistant Escherichia coli in ICU patients].
    Mohammedi I; Denis A; Duperret S; Chapuis F; Ploin D; Petit P
    Ann Fr Anesth Reanim; 2003 Oct; 22(8):711-5. PubMed ID: 14522390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimization of amoxicillin/clavulanate therapy based on pharmacokinetic/pharmacodynamic parameters in patients with diabetic foot infection].
    Sedivý J; Petkov V; Jirkovská A; Stambergová A; Ulbrichová Z; Lupínková J; Fejfarová V; Bém R
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):167-75. PubMed ID: 15328573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia.
    Lin TY; Lin SM; Chen HC; Wang CJ; Wang YM; Chang ML; Wang CH; Liu CY; Lin HC; Yu CT; Hsieh LL; Kuo HP; Huang CD
    Chang Gung Med J; 2007; 30(4):321-32. PubMed ID: 17939262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene.
    Di Conza JA; Badaracco A; Ayala J; Rodríguez C; Famiglietti A; Gutkind GO
    Rev Argent Microbiol; 2014; 46(3):210-7. PubMed ID: 25444130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.